Hummingbird begins Phase Ib trials of HMBD-001 in Australia

Hummingbird begins Phase Ib trials of HMBD-001 in Australia

Source: 
Clinical Trials Arena
snippet: 

Biotechnology company Hummingbird Bioscience has begun two Phase Ib clinical trials of HMBD-001 in Australia.

The trials are enrolling squamous non-small cell lung carcinoma (sqNSCLC) patients and those with genetic aberrations in HER3 signalling.